AstraZeneca PLC (NASDAQ:AZN)
| 57.45 Delayed Data As of 5:22pm ET |  +0.66 / +1.16%Today’s Change | 46.48 Today|||52-Week Range 60.93 | +14.92% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 56.79 |
| Today’s open | 57.66 |
| Day’s range | 56.58 - 57.66 |
| Volume | 1,358,867 |
| Average volume (3 months) | 10,296,907 |
| Market cap | $180.4B |
Data as of 5:22pm ET, 07/27/2021
Growth & Valuation
| Earnings growth (last year) | +138.26% |
| Earnings growth (this year) | +34.57% |
| Earnings growth (next 5 years) | +19.50% |
| Revenue growth (last year) | +13.57% |
| P/E ratio | 37.9 |
| Price/Sales | 4.72 |
| Price/Book | 9.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.66 | +0.85% |
| NVONovo Nordisk | +0.38 | +0.43% |
| BMYBristol-Myers Squibb | -0.20 | -0.30% |
| NVSNovartis | +0.35 | +0.38% |
Data as of 4:58pm ET, 07/27/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $27.8B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
